Clinical trials are the gold standard to determine if our innovative therapies are safe and effective for all patients. At NovaBridge, teams of physicians, scientists and researchers work closely with global investigators to carefully conduct and monitor clinical studies.
Selected Ongoing
Clinical Trials
Givastomig
- Phase 1
- Solid Tumors: Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophagael Junction Carcinoma, Esophageal Adenocarcinoma
Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors
Putting Patients First
Each and every person in our trials plays a powerful role. We are grateful to the patients and families who have participated in our previous and ongoing clinical studies. We work diligently to protect their privacy, dignity, safety and well-being at all times.
Advancing Clinical Research
At NovaBridge we are keenly focused on developing treatments for gastric cancers.
Company Sponsored Trials
To make progress against cancer possible, we are currently conducting clinical studies globally to test the safety and efficacy of our potential new medicines.
Biomarker Research
Providing the right medicine to the right patient is central to NovaBridge’s innovation. Throughout our clinical studies, we create and test approaches to select patients most likely to benefit, to support dose selection, and to enable informed decisions on advancing our therapies to the next phase of testing.
Investigator Sponsored Trials
Consistent with our commitment to scientific innovation and improving patient’s lives, we may provide support for independent investigators to expand scientific knowledge of our treatments by leading their own research projects using our therapies.